| Online-Ressource |
Verfasst von: | Brennenstuhl, Heiko [VerfasserIn]  |
| Kohlmüller, Dirk [VerfasserIn]  |
| Gramer, Gwendolyn [VerfasserIn]  |
| Garbade, Sven [VerfasserIn]  |
| Syrbe, Steffen [VerfasserIn]  |
| Feyh, Patrik [VerfasserIn]  |
| Kölker, Stefan [VerfasserIn]  |
| Okun, Jürgen G. [VerfasserIn]  |
| Hoffmann, Georg F. [VerfasserIn]  |
| Opladen, Thomas [VerfasserIn]  |
Titel: | High throughput newborn screening for aromatic ʟ-amino-acid decarboxylase deficiency by analysis of concentrations of 3-O-methyldopa from dried blood spots |
Verf.angabe: | Heiko Brennenstuhl, Dirk Kohlmüller, Gwendolyn Gramer, Sven F. Garbade, Steffen Syrbe, Patrik Feyh, Stefan Kölker, Jürgen G. Okun, Georg F. Hoffmann, Thomas Opladen |
Jahr: | 2020 |
Jahr des Originals: | 2019 |
Umfang: | 9 S. |
Fussnoten: | First published: 18 December 2019 ; Gesehen am 04.06.2020 |
Titel Quelle: | Enthalten in: Journal of inherited metabolic disease |
Ort Quelle: | Hoboken, NJ : Wiley, 1978 |
Jahr Quelle: | 2020 |
Band/Heft Quelle: | 43(2020), 3, Seite 602-610 |
ISSN Quelle: | 1573-2665 |
Abstract: | Aromatic l-amino-acid decarboxylase (AADC) deficiency is an inherited disorder of biogenic amine metabolism with a broad neurological phenotype. The clinical symptoms overlap with other diseases resulting in an often delayed diagnosis. Innovative disease-changing treatment options, particularly gene therapy, have emphasised the need for an early diagnosis. We describe the first method for 3-O-methyldopa (3-OMD) analysis in dried blood spots (DBS) suitable for high throughput newborn screening (NBS). We established a novel tandem mass spectrometry method to quantify 3-OMD in DBS and successfully tested it in 38 888 unaffected newborns, 14 heterozygous DDC variant carriers, seven known AADC deficient patients, and 1079 healthy control subjects. 3-OMD concentrations in 38 888 healthy newborns revealed a mean of 1.16 μmol/L (SD = 0.31, range 0.31-4.6 μmol/L). 1079 non-AADC control subjects (0-18 years) showed a mean 3-OMD concentration of 0.78 μmol/L (SD = 1.75, range 0.24-2.36 μmol/L) with a negative correlation with age. Inter- and intra-assay variability was low, and 3-OMD was stable over 32 days under different storage conditions. We identified seven confirmed AADC deficient patients (mean 3-OMD 9.88 μmol/L [SD = 13.42, range 1.82-36.93 μmol/L]). The highest concentration of 3-OMD was found in a NBS filter card of a confirmed AADC deficient patient with a mean 3-OMD of 35.95 μmol/L. 14 DDC variant carriers showed normal 3-OMD concentrations. We demonstrate a novel high-throughput method to measure 3-OMD in DBS, which allows integration in existing NBS programs enabling early diagnosis of AADC deficiency. |
DOI: | doi:10.1002/jimd.12208 |
URL: | kostenfrei: Volltext ; Verlag: https://doi.org/10.1002/jimd.12208 |
| kostenfrei: Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/jimd.12208 |
| DOI: https://doi.org/10.1002/jimd.12208 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | 3-O-methyldopa |
| AADC deficiency |
| dried blood spot |
| newborn screening |
| tandem mass spectrometry |
K10plus-PPN: | 1699766436 |
Verknüpfungen: | → Zeitschrift |
|
|
| |
Lokale URL UB: | Zum Volltext |
High throughput newborn screening for aromatic ʟ-amino-acid decarboxylase deficiency by analysis of concentrations of 3-O-methyldopa from dried blood spots / Brennenstuhl, Heiko [VerfasserIn]; 2020 (Online-Ressource)